We are live on ! Find out more
USNA icon

Usana Health Sciences
USNA

145 hedge funds and large institutions have $714M invested in Usana Health Sciences in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 66 increasing their positions, 36 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 36

20% more capital invested

Capital invested by funds: $593M → $714M (+$121M)

16% more call options, than puts

Call options by funds: $4.56M | Put options by funds: $3.92M

3.46% more ownership

Funds ownership: 42% → 45.46% (+3.5%)

6% less funds holding

Funds holding: 155 → 145 (-10)

28% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 25

Holders
145
Holders Change
-10
Holders Change %
-6.45%
% of All Funds
3.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
66
Reduced
36
Closed
25
Calls
$4.56M
Puts
$3.92M
Net Calls
+$636K
Net Calls Change
+$636K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$11.5M
2
Deutsche Bank
Deutsche Bank
Germany
+$6.89M
3
UBS Group
UBS Group
Switzerland
+$6.77M
4
Two Sigma Investments
Two Sigma Investments
New York
+$5.93M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$4.94M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$3.88M
2
Charles Schwab
Charles Schwab
California
-$2.03M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.53M
4
MWNA
Marshall Wace North America
New York
-$1.44M
5
AG
Algert Global
California
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
SEI Investments
126
SEI Investments
Pennsylvania
$33K – – –
Loomis, Sayles & Company
127
Loomis, Sayles & Company
Massachusetts
$26K +$24.8K +402 New
DVM
128
Dreman Value Management
Florida
$26K +$25.3K +411 New
Zurich Cantonal Bank
129
Zurich Cantonal Bank
Switzerland
$24K – – –
GXMC
130
Global X Management Company
New York
$21K +$7.33K +119 +59%
BWA
131
BDO Wealth Advisors
Florida
$12K +$11.1K +180 New
CG
132
Cutler Group
California
$12K +$12.4K +201 New
OC
133
Oakworth Capital
Alabama
$11K – – –
ST
134
Smithfield Trust
Pennsylvania
$10K – – –
IPC
135
Independent Portfolio Consultants
Florida
$8K -$11.7K -190 -61%
FWM
136
Focused Wealth Management
New York
$7K -$123K -2,000 -95%
Nisa Investment Advisors
137
Nisa Investment Advisors
Missouri
$7K – – –
WA
138
WFG Advisors
Texas
$6K – – –
PA
139
Parallel Advisors
California
$3K – – –
DA
140
Denali Advisors
California
$3K +$3.08K +50 New
US Bancorp
141
US Bancorp
Minnesota
$2K – – –
BTIS
142
BB&T Investment Services
North Carolina
$2K +$1.48K +24 New
QI
143
QS Investors
New York
$1K – – –
Walleye Trading
144
Walleye Trading
New York
$236 +$227K +3,680 New
MWNA
145
Marshall Wace North America
New York
– -$1.44M -24,756 Closed
AG
146
Algert Global
California
– -$1.26M -21,843 Closed
TI
147
Trexquant Investment
Connecticut
– -$962K -16,700 Closed
ARTA
148
A.R.T. Advisors
New York
– -$799K -13,876 Closed
HHC
149
Hutchin Hill Capital
New York
– -$714K -12,400 Closed
PL
150
Polianta Ltd
Jersey
– -$669K -11,620 Closed
3 4 5
6
7

USNA Hedge Fund Activity: Q2 2017 in Review

145 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2017, worth a combined $714M — up 20% from $593M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of USNA and 18 opened new positions — a net loss of 7 holders — while 36 trimmed existing stakes and 66 added.

The largest buyer was Renaissance Technologies, adding an estimated $11.5M. The largest seller was Morgan Stanley, cutting an estimated $3.88M.

  • 145 institutional investors held Usana Health Sciences (USNA) as of Q2 2017, down from 155 in Q1 2017.
  • Funds reported $714M of Usana Health Sciences stock for Q2 2017, up 20% quarter-over-quarter.
  • 18 funds opened new Usana Health Sciences positions in Q2 2017 and 25 closed out, a net change of -7 holders.
  • The largest Usana Health Sciences buyer in Q2 2017 was Renaissance Technologies, an estimated $11.5M added.
  • The largest Usana Health Sciences seller in Q2 2017 was Morgan Stanley, an estimated $3.88M sold.

Based on aggregated 13F filings for Q2 2017.